Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001424884-17-000069
Filing Date
2017-08-14
Accepted
2017-08-14 15:20:46
Documents
44
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ON FORM 10-Q cantabio_quarterly_report.htm 10-Q 241789
2 EXHIBIT 31.1 exhibit31_1.htm EX-31.1 10412
3 EXHIBIT 31.2 exhibit31_2.htm EX-31.2 10321
4 EXHIBIT 32.1 exhibit32_1.htm EX-32.1 3592
5 EXHIBIT 32.2 exhibit32_2.htm EX-32.2EX 3789
  Complete submission text file 0001424884-17-000069.txt   1118351

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ctbo-20170630.xml EX-101.INS 109753
7 XBRL TAXONOMY EXTENSION SCHEMA ctbo-20170630.xsd EX-101.SCH 18580
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ctbo-20170630_cal.xml EX-101.CAL 12652
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctbo-20170630_def.xml EX-101.DEF 35540
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctbo-20170630_lab.xml EX-101.LAB 97166
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctbo-20170630_pre.xml EX-101.PRE 88466
Mailing Address 2225 EAST BAYSHORE ROAD PALO ALTO CA 94303
Business Address 2225 EAST BAYSHORE ROAD PALO ALTO CA 94303 844-200-2826
Cantabio Pharmaceuticals Inc. (Filer) CIK: 0001550518 (see all company filings)

EIN.: 990373067 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-54906 | Film No.: 171029655
SIC: 2834 Pharmaceutical Preparations